What is CureApp?
CureApp operates at the intersection of healthcare and technology, specializing in the development of evidence-based medical device programs. The company focuses on addressing clinical conditions that remain inadequately served by conventional hardware or pharmaceutical solutions. By deploying therapeutic applications that function as digital interventions, CureApp provides a scalable, personalized approach to patient management. Their platform is not merely a wellness tool but a rigorous medical solution designed to improve treatment efficacy and patient engagement. Beyond clinical settings, the company extends its expertise to the corporate sector, offering mobile health initiatives that empower organizations to manage employee wellness proactively. This dual-market approach positions CureApp as a versatile player in the digital health ecosystem, capable of delivering value to both healthcare providers and large-scale enterprise clients.
How much funding has CureApp raised?
CureApp has raised a total of $44.7M across 1 funding round:
Series G
$44.7M
Series G (2022): $44.7M with participation from Carlyle
Key Investors in CureApp
Carlyle
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America. The firm manages numerous funds focused on buyouts, venture and growth capital, real estate, and leveraged finance.
What's next for CureApp?
With the successful closure of this major strategic investment, CureApp is well-positioned to transition into a phase of rapid market expansion and product refinement. The company is expected to prioritize the clinical validation of its existing therapeutic pipeline while simultaneously scaling its enterprise health management services. Future strategic initiatives will likely involve deepening partnerships with healthcare providers to integrate their digital therapeutics into standard care pathways, thereby increasing adoption rates and patient accessibility. Furthermore, the firm may leverage this capital to enhance its data analytics capabilities, ensuring that its interventions remain highly personalized and responsive to evolving patient needs. As the digital health landscape matures, CureApp's focus on evidence-based outcomes will be a critical differentiator in securing long-term market leadership and driving sustainable growth in the global healthcare technology sector.
See full CureApp company page
